Methadone Formulation Abuse Resistance via Salt Solubility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug formulations, particularly those containing methadone, are vulnerable to extraction and abuse due to their solubility in aqueous and alcohol solvents, which allows for immediate absorption through injection, inhalation, or oral consumption, necessitating the development of abuse-resistant formulations that maintain pharmacological effectiveness.
Innovation Solution
The use of pharmaceutically acceptable salts of methadone combined with alkalizing agents such as meglumine, trisodium phosphate, and sodium bicarbonate reduces the solubility of the drug in solvents, making extraction more difficult while ensuring the active ingredient remains soluble in the gastrointestinal tract for effective pharmacological action.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If methadone is formulated with high solubility in aqueous solvents, then rapid dissolution and absorption in the gastrointestinal tract is achieved, but extraction and abuse potential increase
Solution Approach 1:
The patent changes the chemical form of methadone from free base to salt form (e.g., methadone hydrochloride, methadone phosphate), which fundamentally alters its solubility parameters. The salt form maintains adequate solubility in gastrointestinal fluids for therapeutic effect while reducing solubility in common extraction solvents like water and alcohol, thereby addressing both dissolution speed and abuse potential
Solution Approach 2:
The formulation uses composite material strategies by combining methadone salts with specific excipients and coating materials that create a matrix with controlled solubility characteristics. This composite approach allows the drug to dissolve appropriately in the gastrointestinal tract while resisting extraction in abuse scenarios
2Object-affected harmful factors
If gel-forming agents are used to prevent extraction, then abuse potential decreases, but immediate release pharmaceutical product performance is compromised
Solution Approach 1:
The patent applies local quality by using different materials with different functions in different parts of the formulation. The methadone salt core provides controlled solubility, while specific excipients and coatings provide extraction resistance. This localized functional differentiation allows abuse deterrence without compromising gastrointestinal release efficiency
Solution Approach 2:
The formulation uses intermediary substances such as specific excipients and coating materials that mediate between the methadone salt and the extraction environment. These intermediaries provide extraction resistance while allowing controlled dissolution in the gastrointestinal tract, thus preventing abuse without compromising therapeutic release
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The formulation significantly reduces the potential for drug abuse by limiting extraction in aqueous and alcohol solvents while allowing for rapid dissolution and absorption in the gastrointestinal tract, maintaining the analgesic effect of methadone.
Implementation Method 1
the narcotic drug has a chemical structure that includes one or more positively charged, protonated amine, and an alkalizing agent
Implementation Method 2
allowing the pharmaceutical formulation to release the active pharmaceutical ingredient in the gastrointestinal tract upon ingestion
Data Source
AI summary
The present application relates to novel narcotic formulations having a decreased injection abuse potential In a representative embodiment, the formulation comprises methadone hydrochloride (6-dimethylamino-4,4-diphenylheptan-3-one, a synthetic opiod), meglumine, cellulose, lactose, and magnesium stearate The application further illustrates methods for making the contemplated formulations.